Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session

Loading...
Loading...

Gainers

  • Crown ElectroKinetics Corp. CRKN jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
  • Core Scientific, Inc. CORZ rose 65% to $0.4125. B. Riley Financial issued an open letter to Core Scientific shareholders and lenders.
  • Scopus BioPharma Inc. SCPS shares jumped 58.1% to $0.3711 after declining 4% on Wednesday.
  • Icosavax, Inc. ICVX shares climbed 42.9% to $12.75. Icosavax shares jumped 112% on Wednesday after the company provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against respiratory syncytial virus
  • IMV Inc. IMV surged 34.4% to $2.89 after the company announced initial data from the ongoing Phase 2B VITALIZE trial in patients with r/r DLBCL.
  • Clearmind Medicine Inc. CMND shares jumped 22.3% to $3.8898. Clearmind Medicine’s CEO, Dr. Adi Zuloff-Shani, issued a letter to shareholders.
  • Kintara Therapeutics, Inc. KTRA rose 18.8% to $9.52. Kintara Therapeutics received orphan drug designation for VAL-083 for treatment of diffuse intrinsic pontine glioma.
  • Lanvin Group Holdings Ltd. LANV gained 18% to $11.75.
  • Iterum Therapeutics plc ITRM surged 18% to $1.34 after the company announced issuance of allowance for a U.S. patent covering oral sulopenem.
  • Troika Media Group, Inc. TRKA gained 17% to $0.12.
  • Astria Therapeutics, Inc. ATXS rose 15.8% to $12.76. Astria Therapeutics announced preliminary results from the Phase 1a trial of STAR-0215 in healthy subjects.
  • Steakholder Foods Ltd. STKH rose 15% to $0.89.
  • Rallybio Corporation RLYB surged 14.1% to $7.20. Rallybio announced publication of data highlighting the ability of HPA-1a-specific antibodies to prevent alloimmunization in an authentic mouse model of FNAIT.
  • Surrozen, Inc. SRZN shares gained 12.6% to $0.4907. The company, last month, posted a narrower Q3 loss.
  • Agilysys, Inc. AGYS jumped 9.7% to $67.79.
  • Blue Apron Holdings, Inc. APRN rose 9% to $0.7020 after the company provided an update on funding from Mr. Joseph Sanberg's affiliates. Blue Apron said it received $1 million of the private placement obligation.
  • Sio Gene Therapies Inc SIOX rose 8.8% to $0.3901. On December 14, 2022, the company’s board unanimously approved the dissolution and liquidation of the company pursuant to a plan of complete liquidation and dissolution.
  • Carvana Co. CVNA gained 8.8% to $5.72. Carvana started offering as-soon-as-next-day touchless home delivery to Corvallis, Oregon, area residents.
  • RCI Hospitality Holdings, Inc. RICK jumped 7.6% to $93.73 folloiwng better-than-expected Q4 results.

 

Losers

  • Third Harmonic Bio, Inc. THRD shares tumbled 78.3% to $4.3090 after the company announced discontinuation of its Phase 1b study of THB001 in chronic inducible urticaria.
  • Miromatrix Medical Inc. MIRO fell 29.3% to $2.8997. The FDA has placed a clinical hold on Miromatrix Medical’s miroliverELAP Investigational New Drug (IND) application for acute liver failure.
  • Panbela Therapeutics, Inc. PBLA fell 20.4% to $0.0948. Panbela recently received EMA opinion on orphan designation for Ivospemin in combination with Gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
  • Novavax, Inc. NVAX shares fell 19.8% to $13.81. Novavax proposed an underwritten public offering to sell up to $125 million of its common stock.
  • MicroAlgo Inc. MLGO declined 19.8% to $2.4050.
  • Axcella Health Inc. AXLA dropped 19.3% to $0.72. Axcella Health announced organizational and program updates, including a reprioritization of its programs for Long COVID Fatigue and Nonalcoholic Steatohepatitis (NASH) and a restructuring of operations.
  • Vallon Pharmaceuticals, Inc. VLON fell 19% to $0.4170. Vallon Pharmaceuticals shares jumped around 105% on Wednesday after the company and GRI Bio announced they entered into a merger agreement.
  • MicroAlgo Inc. MLGO fell 19% to $2.43.
  • Drive Shack Inc. DS shares fell 16.6% to $0.2001. Drive Shack shares dropped around 50% on Wednesday after the company announced the intention to voluntarily delist and deregister its securities.
  • Meiwu Technology Company Limited WNW fell 16.5% to $2.1708 after surging 41% on Wednesday.
  • Roblox Corporation RBLX dropped 15.2% to $28.08 after the company reported November 2022 key metrics.
  • Verve Therapeutics, Inc. VERV fell 12.9% to $19.69 after Goldman Sachs initiated coverage on the stock with a Sell rating and announced a $13 price target.
  • Elys Game Technology, Corp. ELYS declined 11.6% to $0.1630.
  • BIMI International Medical, Inc. BIMI fell 10.7% to $2.5263 after climbing 36% on Wednesday. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd.
  • HUYA Inc. HUYA dropped 10.7% to $3.00.
  • Alight, Inc. ALIT fell 10.6% to $8.02. Alight, last week, announced the acquisition of ReedGroup.
  • Indaptus Therapeutics, Inc. INDP declined 10.3% to $1.5601.
  • Checkpoint Therapeutics, Inc. CKPT fell 10.2% to $4.33. Checkpoint Therapeutics announced a $7.5 million registered direct offering priced at-the-market under Nasdaq rules.
  • Shore Bancshares, Inc. SHBI declined 8.3% to $17.47. Shore Bancshares and The Community Financial Corporation announced merger of equals to create bank with $6 billion in assets.x
  • NantHealth, Inc. NH dropped 8.6% to $0.2150. NantHealth announced a 1-for-15 reverse stock split.
  • GlycoMimetics, Inc. GLYC shares fell 8.5% to $2.0213.

Also check this out 5 Most Overvalued Stocks In The Industrials Sector: Aerojet Rocketdyne, Triton International And More.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day Movers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...